Abstract

In the malaria parasite Plasmodium falciparum, the cellular redox potential influences signaling events, antioxidant defense, and mechanisms of drug action and resistance. Until now, the real-time determination of the redox potential in malaria parasites has been limited because conventional approaches disrupt sub-cellular integrity. Using a glutathione biosensor comprising human glutaredoxin-1 linked to a redox-sensitive green fluorescent protein (hGrx1-roGFP2), we systematically characterized basal values and drug-induced changes in the cytosolic glutathione-dependent redox potential (E GSH) of drug-sensitive (3D7) and resistant (Dd2) P. falciparum parasites. Via confocal microscopy, we demonstrated that hGrx1-roGFP2 rapidly detects E GSH changes induced by oxidative and nitrosative stress. The cytosolic basal E GSH of 3D7 and Dd2 were estimated to be −314.2±3.1 mV and −313.9±3.4 mV, respectively, which is indicative of a highly reducing compartment. We furthermore monitored short-, medium-, and long-term changes in E GSH after incubation with various redox-active compounds and antimalarial drugs. Interestingly, the redox cyclers methylene blue and pyocyanin rapidly changed the fluorescence ratio of hGrx1-roGFP2 in the cytosol of P. falciparum, which can, however, partially be explained by a direct interaction with the probe. In contrast, quinoline and artemisinin-based antimalarial drugs showed strong effects on the parasites' E GSH after longer incubation times (24 h). As tested for various conditions, these effects were accompanied by a drop in total glutathione concentrations determined in parallel with alternative methods. Notably, the effects were generally more pronounced in the chloroquine-sensitive 3D7 strain than in the resistant Dd2 strain. Based on these results hGrx1-roGFP2 can be recommended as a reliable and specific biosensor for real-time spatiotemporal monitoring of the intracellular E GSH in P. falciparum. Applying this technique in further studies will enhance our understanding of redox regulation and mechanisms of drug action and resistance in Plasmodium and might also stimulate redox research in other pathogens.

Highlights

  • Malaria is a major disease burden in 106 countries, causing an estimated 225 million cases and, as reported for 2010, 665,000 to 1,133,000 human deaths each year in tropical and sub-tropical regions [1]

  • By targeting this probe to the parasites’ cytosol, we were able to verify its stability and responsiveness to the redox environment. Using this probe in living parasites, we further studied the effects of various redox active compounds and antimalarial drugs on the cytosolic glutathione redox potential in short, medium, and long-term experiments

  • We confirmed the expression of the fulllength fusion human glutaredoxin-1 (hGrx1)-roGFP2 protein with the predicted size of 47 kDa in parasite lysates of 3D7 (3D7hGrx1-roGFP2) and Dd2 (Dd2hGrx1-roGFP2) strains via western blotting (Fig. S1)

Read more

Summary

Introduction

Malaria is a major disease burden in 106 countries, causing an estimated 225 million cases and, as reported for 2010, 665,000 to 1,133,000 human deaths each year in tropical and sub-tropical regions [1]. Cellular redox reactions play important roles in redox regulatory processes and antioxidant defense and in the mechanisms of drug action and drug resistance in malaria parasites [3,4]. Non-crystallized toxic heme exits the food vacuole and is degraded in the cytosol with GSH as a cofactor. This process is inhibited by chloroquine (CQ) and amodiaquine (AQ) [13], leading to an intensive discussion about the role of oxidative stress in the mechanism of action of 4aminoquinolines [14,15,16]. Redox metabolism seems to play an important role in antimalarial drug action and resistance and deserves to be studied in more detail

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call